Regulon

Regulon: R-365

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
72.0765717Pr-10Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
6482 ENSG00000008513 ST3GAL1 Q11201
7414 ENSG00000035403 VCL V9HWK2
4790 ENSG00000109320 NFKB1 P19838
2335 ENSG00000115414 FN1 P02751
5045 ENSG00000140564 FURIN P09958
6778 ENSG00000166888 STAT6 P42226
254102 ENSG00000173442 EHBP1L1 Q8N3D4

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
EDASALONEXENTNFKB2Small moleculeINHIBITORNuclear factor NF-kappa-B complex inhibitor30
L19IL2FN1AntibodyBINDING AGENTFibronectin binding agent30
AS-1409FN1AntibodyBINDING AGENTFibronectin binding agent10
L19TNFAFN1AntibodyBINDING AGENTFibronectin binding agent20
L19SIP 131IFN1AntibodyOTHERFibronectin other20
OCRIPLASMINLAMA2EnzymePROTEOLYTIC ENZYMEFibronectin proteolytic enzyme40

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-365

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-04678RUSC2down-regulatesATF5activatesR-365143Drugs (6)

Regulator Drugs (0)

Regulon Drugs (6)

EDASALONEXENT, L19IL2, AS-1409, L19TNFA, L19SIP 131I, OCRIPLASMIN

CMF-05023NUP210Ldown-regulatesATF5activatesR-365143Drugs (6)

Regulator Drugs (0)

Regulon Drugs (6)

EDASALONEXENT, L19IL2, AS-1409, L19TNFA, L19SIP 131I, OCRIPLASMIN

CMF-05765ADAMTS19down-regulatesATF5activatesR-365145Drugs (6)

Regulator Drugs (0)

Regulon Drugs (6)

EDASALONEXENT, L19IL2, AS-1409, L19TNFA, L19SIP 131I, OCRIPLASMIN

CMF-10226SEMG1down-regulatesATF5activatesR-365144Drugs (6)

Regulator Drugs (0)

Regulon Drugs (6)

EDASALONEXENT, L19IL2, AS-1409, L19TNFA, L19SIP 131I, OCRIPLASMIN

CMF-17146CDH18up-regulatesATF5activatesR-365144Drugs (6)

Regulator Drugs (0)

Regulon Drugs (6)

EDASALONEXENT, L19IL2, AS-1409, L19TNFA, L19SIP 131I, OCRIPLASMIN

CMF-17977PRPF40Bdown-regulatesATF5activatesR-3651410Drugs (6)

Regulator Drugs (0)

Regulon Drugs (6)

EDASALONEXENT, L19IL2, AS-1409, L19TNFA, L19SIP 131I, OCRIPLASMIN

CMF-19295NF1up-regulatesATF5activatesR-3651411Drugs (6)

Regulator Drugs (0)

Regulon Drugs (6)

EDASALONEXENT, L19IL2, AS-1409, L19TNFA, L19SIP 131I, OCRIPLASMIN